Efficacy and safety of telitacicept in systemic lupus erythematosus: a single-center, retrospective, real-world study
ObjectiveTo explore the real-world efficacy and safety of telitacicept in patients with systemic lupus erythematosus (SLE).MethodsThis retrospective study included SLE patients treated with telitacicept for at least 3 months at Mianyang Central Hospita…